BioDRestore™ Elemental Tissue Matrix is a morselized, flowable tissue allograft derived from amniotic tissues. Amniotic tissues have been shown to support soft tissue repair, reduce inflammation and minimize scar tissue formation. Clinicians have used amniotic tissues for over a century as a biologic dressing in a broad range of therapeutic applications with positive clinical outcomes. It has been generally recognized as a versatile wound covering with published clinical results cited extensively in the literature.

  • Extracellular matrix composition of Collagens I, III, IV, V, VII and other structural proteins provides a natural scaffold to facilitate cellular adhesion while assisting cellular migration and proliferation
  • Growth factors found in amniotic tissue such as PDGF, VEGF, EGF, FGF and TGF-B promote cellular proliferation and new collagen formation and minimize scar tissue formation
  • Interleukin-1 receptor antagonists (IL-1RA)
  • TIMP-1, 2, and 4 present in amniotic tissue aid wound healing by suppressing inflammation and pain as well as organizing extracellular matrix composition
  • Amniotic tissues have been described as immune-privileged because they rarely evoke an immune response in the human body
  • AM-010025 – SMALL (0.25cc)
  • AM-010050 – MEDIUM (0.50cc)
  • AM-010125 – LARGE (1.0cc)
  • AM-010200 – EXTRA LARGE (2.0cc)
  • AM-010300 – XX LARGE (3.0cc)